Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Orange SA | 4.48% | $6.55M | $52.77B | 84.27% | 63 Neutral | |
| GlaxoSmithKline | 4.35% | $6.36M | $123.00B | 66.08% | 77 Outperform | |
| BNP Paribas | 3.82% | $5.59M | $122.41B | 50.17% | 72 Outperform | |
| Reckitt Benckiser Group | 3.62% | $5.28M | $56.11B | 25.38% | 78 Outperform | |
| Enel SpA Unsponsored ADR | 3.45% | $5.04M | $110.95B | 48.04% | 71 Outperform | |
| Royal KPN | 3.44% | $5.03M | $20.66B | 50.69% | 68 Neutral | |
| Petroleo Brasileiro SA- Petrobras | 3.33% | $4.86M | $95.23B | 6.78% | 69 Neutral | |
| TSMC | 3.29% | $4.81M | $1.57T | 81.79% | 81 Outperform | |
| British American Tobacco | 3.13% | $4.57M | $126.61B | 61.14% | 59 Neutral | |
| Rio Tinto | 2.83% | $4.14M | $167.64B | 51.64% | 80 Outperform |